Materialise NV (NASDAQ:MTLS), a leading provider of additive
manufacturing and medical software and of sophisticated 3D printing
services, today announced its financial results for the first
quarter ended March 31, 2023.
Highlights – First Quarter 2023
- Total revenue increased 24.4% to 65,886 kEUR compared to 52,961
kEUR for the first quarter of 2022.
- Total deferred revenues from annual software sales and
maintenance fees increased by 1,728 kEUR this quarter to 44,508
kEUR.
- Adjusted EBITDA increased to 10,310 kEUR for the first quarter
of 2023 from 5,443 kEUR for the 2022 period.
- Net profit for the first quarter of 2023 was 3,715 kEUR, or
0.06 EUR per diluted share, compared to 127 kEUR, or 0.00 EUR per
diluted share, for the 2022 period.
Executive Chairman Peter Leys commented, “Materialise performed
extremely well in the year’s opening quarter. Our consolidated
revenues increased more than 24%, boosted by the very strong growth
of Materialise Medical and Materialise Manufacturing revenues, by
33% and 25% respectively, and further supported by a solid revenue
uptake at Materialise Software of more than 8%. During the quarter,
our Adjusted EBITDA increased 89% to 10,310 kEUR, mainly because of
scaling effects.”
First Quarter 2023 Results
Total revenue for the first quarter of 2023 increased 24.4% to
65,886 kEUR from 52,961 kEUR for the first quarter of 2022.
Adjusted EBITDA increased to 10,310 kEUR for the first quarter of
2023 from 5,443 kEUR for the 2022 period. The Adjusted EBITDA
margin (Adjusted EBITDA divided by total revenue) for the first
quarter of 2023 was 15.6%, compared to 10.3% for the first quarter
of 2022.
Revenue from Materialise Software increased 8.3% to 11,350 kEUR
for the first quarter of 2023 from 10,483 kEUR for the same quarter
last year. Segment Adjusted EBITDA increased to 2,427 kEUR from
1,932 kEUR while the segment Adjusted EBITDA margin was 21.4%
compared to 18.4% for the prior-year period.
Revenue from our Materialise Medical segment increased 32.5% to
24,317 kEUR for the first quarter of 2023 compared to 18,347 kEUR
for the same period in 2022. Segment Adjusted EBITDA increased to
7,348 kEUR for the first quarter of 2023 compared to 3,227 kEUR
while the segment Adjusted EBITDA margin grew to 30.2% compared to
17.6% for the first quarter of 2022.
Revenue from our Materialise Manufacturing segment increased
25.2% to 30,219 kEUR for the first quarter of 2023 from 24,131 kEUR
for the first quarter of 2022. Segment Adjusted EBITDA increased to
3,189 kEUR from 2,613 kEUR while the segment Adjusted EBITDA margin
was 10.6% compared to 10.8% for the first quarter of 2022.
Gross profit grew to 36,837 kEUR compared to 28,884 kEUR for the
same period last year, while gross profit as a percentage of
revenue increased to 55.9% compared to 54.5% for the first quarter
of 2022.
Research and development (“R&D”), sales and marketing
(“S&M”) and general and administrative (“G&A”) expenses
increased, in the aggregate, 8.7% to 32,358 kEUR for the first
quarter of 2023 from 29,774 kEUR for the first quarter of 2022.
Net other operating income was 519 kEUR compared to 938 kEUR for
the first quarter of 2022.
Operating result amounted to 4,998 kEUR compared to 49 kEUR for
the first quarter of 2022.
Net financial result was (566) kEUR compared to 376 kEUR for the
first quarter of 2022.
The first quarter of 2023 contained income tax expenses of (718)
kEUR, compared to (298) kEUR in the first quarter of 2022.
As a result of the above, net profit for the first quarter of
2023 was 3,715 kEUR, compared to 127 kEUR for the same period in
2022. Total comprehensive income for the first quarter of 2023,
which includes exchange differences on translation of foreign
operations, was 4,490 kEUR compared to 1,543 kEUR for the 2022
period.
At March 31, 2023, we had cash and cash equivalents of 141,720
kEUR compared to 140,867 kEUR at December 31, 2022. Gross debt
amounted to 75,251 kEUR, compared to 80,980 kEUR at December 31,
2022. As a result, our net cash position (gross debt less cash and
cash equivalents) increased 6,582 kEUR to 66,469 kEUR.
Cash flow from operating activities for the first quarter of
2023 decreased to 11,044 kEUR from 11,111 kEUR for the same period
in 2022. Total capital expenditures for the first quarter of 2023
amounted to 3,271 kEUR.
Net shareholders’ equity at March 31, 2023 was 233,251 kEUR
compared to 228,928 kEUR at December 31, 2022.
2023 Guidance
Executive Chairman Peter Leys concluded, “In the beginning of
2023, we expected Materialise to report consolidated revenue
between 255,000 kEUR and 260,000 kEUR and Adjusted EBITDA between
25,000 kEUR and 30,000 kEUR. Based on the company’s strong Q1
performance, but also bearing in mind the uncertain global
macro-economic environment, we now believe that our 2023 revenue
will come closer to the high end of the initially guided range, and
expect that our 2023 Adjusted EBITDA could be up to 10% higher than
the top of the range communicated earlier.”
Non-IFRS Measures
Materialise uses EBITDA and Adjusted EBITDA as supplemental
financial measures of its financial performance. EBITDA is
calculated as net profit plus income taxes, financial expenses
(less financial income), shares of profit or loss in a joint
venture and depreciation and amortization. Adjusted EBITDA is
determined by adding share-based compensation expenses,
acquisition-related expenses of business combinations, impairments
and revaluation of fair value due to business combinations to
EBITDA. Management believes these non-IFRS measures to be important
measures as they exclude the effects of items which primarily
reflect the impact of long-term investment and financing decisions,
rather than the performance of the company’s day-to-day operations.
As compared to net profit, these measures are limited in that they
do not reflect the periodic costs of certain capitalized tangible
and intangible assets used in generating revenues in the company’s
business, or the charges associated with impairments. Management
evaluates such items through other financial measures such as
capital expenditures and cash flow provided by operating
activities. The company believes that these measurements are useful
to measure a company’s ability to grow or as a valuation
measurement. The company’s calculation of EBITDA and Adjusted
EBITDA may not be comparable to similarly titled measures reported
by other companies. EBITDA and Adjusted EBITDA should not be
considered as alternatives to net profit or any other performance
measure derived in accordance with IFRS. The company’s presentation
of EBITDA and Adjusted EBITDA should not be construed to imply that
its future results will be unaffected by unusual or non-recurring
items.
Exchange Rate
This document contains translations of certain euro amounts into
U.S. dollars at specified rates solely for the convenience of
readers. Unless otherwise noted, all translations from euros to
U.S. dollars in this document were made at a rate of EUR 1.00 to
USD 1.0875, the reference rate of the European Central Bank on
March 31, 2023.
Conference Call and Webcast
Materialise will hold a conference call and simultaneous webcast
to discuss its financial results for the first quarter of 2023 on
Thursday, April 27, 2023, at 8:30 a.m. ET/2:30 p.m. CET. Company
participants on the call will include Wilfried Vancraen, Founder
and Chief Executive Officer; Peter Leys, Executive Chairman; and
Johan Albrecht, Chief Financial Officer. A question-and-answer
session will follow management’s remarks.
To access the call by phone, please click the link below at
least 15 minutes prior to the scheduled start time and you will be
provided with dial-in details. Participants can choose to dial in
or receive a call to connect to Materialise’s conference call.
-
https://register.vevent.com/register/BIce3a939d16b0475c9bfcecc011563924
The conference call will also be broadcast live over the
Internet with an accompanying slide presentation, which can be
accessed on the company’s website at
http://investors.materialise.com. A webcast of the conference call
will be archived on the company's website.
About Materialise
Materialise incorporates 30 years of 3D printing experience into
a range of software solutions and 3D printing services, which form
the backbone of the 3D printing industry. Materialise’s open and
flexible solutions enable players in a wide variety of industries,
including healthcare, automotive, aerospace, art and design, and
consumer goods, to build innovative 3D printing applications that
aim to make the world a better and healthier place. Headquartered
in Belgium, with branches worldwide, Materialise combines one of
the largest groups of software developers in the industry with one
of the largest 3D printing facilities in the world. For additional
information, please visit: www.materialise.com.
Cautionary Statement on Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended, regarding, among other things, our intentions, beliefs,
assumptions, projections, outlook, analyses or current
expectations, plans, objectives, strategies and prospects, both
financial and business, including statements concerning, among
other things, our current estimates for fiscal 2023 revenue and
Adjusted EBITDA, our results of operations, cash needs, capital
expenditures, expenses, financial condition, liquidity, prospects,
growth and strategies (including how our business, results of
operations and financial condition could be impacted by the ongoing
military conflict between Ukraine and Russia and economic sanctions
related thereto as well as by inflation and increased labor, energy
and materials costs), and the trends and competition that may
affect the markets, industry or us. Such statements are subject to
known and unknown uncertainties and risks. When used in this press
release, the words “estimate,” “expect,” “anticipate,” “project,”
“plan,” “intend,” “believe,” “forecast,” “will,” “may,” “could,”
“might,” “aim,” “should,” and variations of such words or similar
expressions are intended to identify forward-looking statements.
These forward-looking statements are based upon the expectations of
management under current assumptions at the time of this press
release. These expectations, beliefs and projections are expressed
in good faith and the company believes there is a reasonable basis
for them. However, the company cannot offer any assurance that our
expectations, beliefs and projections will actually be achieved. By
their nature, forward-looking statements involve risks and
uncertainties because they relate to events, competitive dynamics
and industry change, and depend on economic circumstances that may
or may not occur in the future or may occur on longer or shorter
timelines than anticipated. We caution you that forward-looking
statements are not guarantees of future performance and involve
known and unknown risks, uncertainties and other factors that are
in some cases beyond our control. All of the forward-looking
statements are subject to risks and uncertainties that may cause
the company's actual results to differ materially from our
expectations, including risk factors described in the company's
most recent annual report on Form 20-F filed with the U.S.
Securities and Exchange Commission. There are a number of risks and
uncertainties that could cause the company's actual results to
differ materially from the forward-looking statements contained in
this press release.
The company is providing this information as of the date of this
press release and does not undertake any obligation to update any
forward-looking statements contained in this press release as a
result of new information, future events or otherwise, unless it
has obligations under the federal securities laws to update and
disclose material developments related to previously disclosed
information.
Consolidated income statements
(Unaudited)
for the three months endedMarch 31, In '000
2023
2023
2022
U.S.$ € € Revenue
71,651
65,886
52,961
Cost of Sales
(31,591)
(29,049)
(24,078)
Gross Profit
40,060
36,837
28,884
Gross profit as % of revenue
55.9%
55.9%
54.5%
Research and development expenses
(9,802)
(9,014)
(7,814)
Sales and marketing expenses
(15,539)
(14,288)
(13,515)
General and administrative expenses
(9,848)
(9,056)
(8,444)
Net other operating income (expenses)
565
519
938
Operating (loss) profit
5,436
4,998
49
Financial expenses
(1,495)
(1,375)
(1,289)
Financial income
880
809
1,665
Share in loss of joint venture
-
-
-
(Loss) profit before taxes
4,821
4,432
425
Income Taxes
(780)
(718)
(298)
Net (loss) profit for the period
4,041
3,715
127
Net (loss) profit attributable to:
-
The owners of the parent
4,047
3,721
134
Non-controlling interest
(7)
(7)
(7)
Earning per share attributable to owners of the
parent Basic
0.07
0.06
0.00
Diluted
0.07
0.06
0.00
Weighted average basic shares outstanding
59,067
59,067
59,064
Weighted average diluted shares outstanding
59,070
59,070
59,102
Consolidated statements of
comprehensive income (Unaudited)
for the three months endedMarch 31, In 000€
2023
2023
2022
U.S.$ € € Net profit (loss) for the
period
4,041
3,715
127
Other comprehensive income Recycling Exchange
difference on translation of foreign operations
843
776
1,416
Non-recycling Fair value adjustments through OCI - Equity
instruments
-
-
-
Other comprehensive income (loss), net of taxes
843
776
1,416
Total comprehensive income (loss) for the year, net of taxes
4,883
4,490
1,543
Total comprehensive income (loss) attributable to: The owners of
the parent
4,890
4,496
1,549
Non-controlling interests
(6)
(6)
(7)
Consolidated statement of financial
position (Unaudited)
As ofMarch 31, As ofDecember 31, In 000€
2023
2022
Assets Non-current assets Goodwill
44,196
44,155
Intangible assets
36,944
37,875
Property, plant & equipment
94,462
94,276
Right-of-Use assets
8,323
8,420
Investments in joint ventures
-
-
Deferred tax assets
1,208
1,186
Investments in convertible loans
3,555
3,494
Investments in non-listed equity instruments
307
307
Other non-current assets
5,414
5,136
Total non-current assets
194,409
194,847
Current assets Inventories
15,810
16,081
Trade receivables
47,780
51,043
Other current assets
8,114
8,424
Cash and cash equivalents
141,720
140,867
Total current assets
213,423
216,414
Total assets
407,833
411,262
As ofMarch 31, As ofDecember 31, In 000€
2023
2022
Equity and liabilities Equity Share capital
4,487
4,487
Share premium
233,895
233,895
Retained earnings and other reserves
(5,097)
(9,427)
Equity attributable to the owners of the parent
233,285
228,955
Non-controlling interest
(34)
(28)
Total equity
233,251
228,928
Non-current liabilities Loans & borrowings
51,035
55,873
Lease liabilities
4,964
5,147
Deferred tax liabilities
4,167
4,312
Deferred income
8,858
9,277
Other non-current liabilities
504
1,611
Total non-current liabilities
69,528
76,220
Current liabilities Loans & borrowings
16,328
17,058
Lease liabilities
2,924
2,902
Trade payables
23,776
23,230
Tax payables
1,922
1,246
Deferred income
43,474
41,721
Other current liabilities
16,630
19,957
Total current liabilities
105,054
106,114
Total equity and liabilities
407,833
411,262
Consolidated statement of cash flows
(Unaudited)
for the three months endedMarch 31, In 000€
2023
2022
Operating activities Net (loss) profit for the period
3,715
127
Non-cash and operational adjustments Depreciation of property plant
& equipment
3,637
3,840
Amortization of intangible assets
1,674
1,602
Impairment of goodwill and intangible assets
-
-
Share-based payment expense
-
(48)
Loss (gain) on disposal of intangible assets and property, plant
& equipment
(22)
(18)
Movement in provisions
(618)
2
Movement reserve for bad debt and slow moving inventory
109
130
Financial income
(767)
(1,618)
Financial expense
1,375
1,237
Impact of foreign currencies
6
(28)
(Deferred) income taxes
717
302
Working capital adjustments
850
5,923
Decrease (increase) in trade receivables and other receivables
3,363
4,506
Decrease (increase) in inventories and contracts in progress
262
(1,357)
Increase (decrease) in deferred revenue
1,368
3,665
Increase (decrease) in trade payables and other payables
(4,142)
(891)
Income tax paid & Interest received
367
(341)
Net cash flow from operating activities
11,044
11,111
for the three months endedMarch 31, In 000€
2023
2022
Investing activities Purchase of property, plant &
equipment
(2,532)
(2,376)
Purchase of intangible assets
(738)
(1,123)
Proceeds from the sale of property, plant & equipment &
intangible assets (net)
100
93
Acquisition of subsidiary (net of cash)
-
(27,414)
Net cash flow used in investing activities
(3,171)
(30,820)
Financing activities Repayment of loans & borrowings
(5,635)
(5,969)
Repayment of leases
(859)
(881)
Interest paid
(417)
(515)
Other financial income (expense)
(108)
(89)
Net cash flow from (used in) financing activities
(7,019)
(7,452)
Net increase/(decrease) of cash & cash equivalents
854
(27,161)
Cash & Cash equivalents at the beginning of the year
140,867
196,028
Exchange rate differences on cash & cash equivalents
(1)
743
Cash & cash equivalents at end of the period
141,720
169,610
Reconciliation of Net Profit (Loss) to
EBITDA and Adjusted EBITDA (Unaudited)
for the three months endedMarch 31, In 000€
2023
2022
Net profit (loss) for the period
3,715
127
Income taxes
718
298
Financial expenses
1,375
1,289
Financial income
(809)
(1,665)
Depreciation and amortization
5,311
5,442
EBITDA
10,310
5,491
Share-based compensation expense (1)
-
(48)
Adjusted EBITDA
10,310
5,443
(1) Share-based compensation expense represents the cost of
equity-settled and share-based payments to employees.
Segment P&L (Unaudited)
In 000€
MaterialiseSoftware MaterialiseMedical
MaterialiseManufacturing Totalsegments Unallocated
(1) Consolidated For the three months ended March 31,
2023 Revenues
11,350
24,317
30,219
65,886
0
65,886
Segment (adj) EBITDA
2,427
7,348
3,189
12,964
(2,655)
10,310
Segment (adj) EBITDA %
21.4%
30.2%
10.6%
19.7%
15.6%
For the three months ended March 31, 2022 Revenues
10,483
18,347
24,131
52,961
0
52,961
Segment (adj) EBITDA
1,932
3,227
2,613
7,772
(2,329)
5,443
Segment (adj) EBITDA %
18.4%
17.6%
10.8%
14.7%
10.3%
(1)
Unallocated segment adjusted EBITDA
consists of corporate research and development and corporate other
operating income (expense), and the added share-based compensation
expenses, acquisition related expenses of business combinations,
impairments and fair value of business combinations that are
included in Adjusted EBITDA.
Reconciliation of Net Profit (Loss) to
Segment adjusted EBITDA (Unaudited)
for the three months endedMarch 31, In 000€
2023
2022
Net profit (loss) for the period
3,715
127
Income taxes
718
298
Financial cost
1,375
1,289
Financial income
(809)
(1,665)
Operating (loss) profit
4,998
49
Depreciation and amortization
5,311
5,442
Corporate research and development
722
816
Corporate headquarter costs
2,640
2,106
Other operating income (expense)
(707)
(640)
Segment adjusted EBITDA
12,964
7,772
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230427005072/en/
Investor Relations Harriet Fried LHA 212.838.3777
hfried@lhai.com
Materialise NV (NASDAQ:MTLS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Materialise NV (NASDAQ:MTLS)
Historical Stock Chart
From Apr 2023 to Apr 2024